AngioSoma, Inc.·5

Aug 29, 4:50 PM ET

Blankenship Alex K 5

5 · AngioSoma, Inc. · Filed Aug 29, 2019

Insider Transaction Report

Form 5
Period: 2017-09-30
Blankenship Alex K
DirectorCEO, Pres., Secr., Treas.
Transactions
  • Purchase

    Series E preferred stock

    2016-08-11$1000.00/sh+1,000,000$1,000,000,0001,000,000 total
  • Purchase

    Common stock

    2017-07-19$2000.00/sh+2,000,000$4,000,000,0002,500,000 total

Documents

1 file
  • 5
    primary_doc.xmlPrimary

    PRIMARY DOCUMENT